Massaro, A. N., Boyer, B., Gill, M., Kim, D., Laughon, M., Walsh, M., … Duke-Margolis/FDA Measuring Clinical Benefit in Neonatal RCTs Workshop Participants. (2024). Measuring Clinical Benefit in Neonatal Randomized Clinical Trials: Challenges and Opportunities. J Pediatr, 269, 113972. https://doi.org/10.1016/j.jpeds.2024.113972

Massaro, An N., Beth Boyer, Mira Gill, Dure Kim, Matthew Laughon, Michele Walsh, Monica E. Lemmon, Betsy Pilon, Gerri Baer, and Duke-Margolis/FDA Measuring Clinical Benefit in Neonatal RCTs Workshop Participants. “Measuring Clinical Benefit in Neonatal Randomized Clinical Trials: Challenges and Opportunities.” J Pediatr 269 (June 2024): 113972. https://doi.org/10.1016/j.jpeds.2024.113972.

Massaro AN, Boyer B, Gill M, Kim D, Laughon M, Walsh M, et al. Measuring Clinical Benefit in Neonatal Randomized Clinical Trials: Challenges and Opportunities. J Pediatr. 2024 Jun;269:113972.

Massaro, An N., et al. “Measuring Clinical Benefit in Neonatal Randomized Clinical Trials: Challenges and Opportunities.” J Pediatr, vol. 269, June 2024, p. 113972. Pubmed, doi:10.1016/j.jpeds.2024.113972.

Massaro AN, Boyer B, Gill M, Kim D, Laughon M, Walsh M, Lemmon ME, Pilon B, Baer G, Duke-Margolis/FDA Measuring Clinical Benefit in Neonatal RCTs Workshop Participants. Measuring Clinical Benefit in Neonatal Randomized Clinical Trials: Challenges and Opportunities. J Pediatr. 2024 Jun;269:113972.